Treatment of Type I Hepatorenal Syndrome (HRS) With Pentoxyfylline

NCT02123576 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

12

Enrollment

OTHER

Sponsor class

Stopped Poor enrollment of study population

Conditions

Hepatorenal Syndrome

Interventions

DRUG: Pentoxyfylline
DRUG: Placebo
DRUG: AMO Therapy

Sponsor

Patrick Northup, MD